Literature DB >> 25098433

A case of primary neuroendocrine breast carcinoma that responded to neo-adjuvant chemotherapy.

Xiaolong Wei1, Chunfa Chen, Didi Xi, Jinwen Bai, Wenhe Huang, Luoxiang Rong, Mingyao Wu, Guojun Zhang.   

Abstract

Primary neuroendocrine breast carcinoma (NEBC) is a very rare type of breast cancer. Two characteristic biomarkers, namely, CgA and Syn, should be immunohistochemically detected to diagnose NEBC. In this study, a 43-year-old woman with a large mass of 8.3 cm × 2.9 cm in her right breast was reported. The patient was pathologically diagnosed with NEBC after specific markers, including CgA and Syn, as well as few differential markers, such as CK7, ER, PR, C-erbB-2, NSE, and E-cadherin, were immunohistochemically detected. The patient showed a remarkable response to four cycles of neo-adjuvant chemotherapy (partial response based on RECIST criteria) and sequentially underwent modified radical mastectomy. Moreover, the diagnosis and treatment of NEBC based on this case and available related literature were discussed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25098433     DOI: 10.1007/s11684-014-0345-z

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  14 in total

Review 1.  Expression of the neuroendocrine phenotype in carcinomas of the breast.

Authors:  A Sapino; L Righi; P Cassoni; M Papotti; F Pietribiasi; G Bussolati
Journal:  Semin Diagn Pathol       Date:  2000-05       Impact factor: 3.464

2.  [ON THE CARCINOID GROWTH FORM OF THE CARCINOMA MAMMAE, ESPECIALLY THE CARCINOMA SOLIDUM (GELATINOSUM) MAMMAE].

Authors:  F FEYRTER; G HARTMANN
Journal:  Frankf Z Pathol       Date:  1963-10-03

3.  Radiologic characteristics and management of screen-detected metastatic carcinoid tumor of the breast: a case report.

Authors:  Rosie F Adams; Vaishali Parulekar; Caroline Hughes; Michael J Kadour; Denis Talbot
Journal:  Clin Breast Cancer       Date:  2009-08       Impact factor: 3.225

4.  Neuroendocrine differentiation in carcinomas of the breast: a study of 51 cases.

Authors:  M Papotti; L Macrì; G Finzi; C Capella; V Eusebi; G Bussolati
Journal:  Semin Diagn Pathol       Date:  1989-05       Impact factor: 3.464

5.  A rare breast tumor: solid neuroendocrine carcinoma.

Authors:  Alessandro Sanguinetti; Stefano Santoprete; Roberta Lucchini; Roberta Triola; Fabio Loreti; Nicola Avenia
Journal:  Ann Ital Chir       Date:  2013 Jan-Feb       Impact factor: 0.766

6.  [WHO classification of breast tumors and tumors of the female genital organs: pathology and genetics].

Authors:  W Böcker
Journal:  Verh Dtsch Ges Pathol       Date:  2002

7.  A monoclonal antibody against neuron-specific enolase. Immunohistochemical comparison with a polyclonal antiserum.

Authors:  P Thomas; H Battifora; G L Manderino; J Patrick
Journal:  Am J Clin Pathol       Date:  1987-08       Impact factor: 2.493

8.  A case of solid neuroendocrine carcinoma of the breast in a 40-year-old woman.

Authors:  Yasuhisa Fujimoto; Ryuuichirou Yagyu; Keiko Murase; Hidemi Kawajiri; Hiroshi Ohtani; Yuichi Arimoto; Takehira Yamamura; Takeshi Inoue; Suzuko Moritani
Journal:  Breast Cancer       Date:  2007       Impact factor: 4.239

Review 9.  Carcinomas of the breast with endocrine differentiation: a review.

Authors:  H M Maluf; F C Koerner
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

10.  'Carcinoid' tumours of the breast: the morphological spectrum of argyrophil carcinomas.

Authors:  J G Azzopardi; P Muretto; P Goddeeris; V Eusebi; J M Lauweryns
Journal:  Histopathology       Date:  1982-09       Impact factor: 5.087

View more
  8 in total

1.  Primary neuroendocrine tumors of the breast: About a case and of the review of the literature.

Authors:  K Fares El Arab; M Bourhafour; R Elqasseh; A Khoaja; Z Bouchbika; N Benchakroun; H Jouhadi; N Tawfiq; M Ennachit; M Elkarroumi; Abdellatif Benider; S Sahraoui
Journal:  Int J Surg Case Rep       Date:  2022-09-15

Review 2.  Primary Neuroendocrine Tumor of the Breast: Current Understanding and Future Perspectives.

Authors:  Hongna Sun; Shuang Dai; Junnan Xu; Linan Liu; Jiaxing Yu; Tao Sun
Journal:  Front Oncol       Date:  2022-05-25       Impact factor: 5.738

Review 3.  Neuroendocrine Carcinoma of the Breast: Current Evidence and Future Perspectives.

Authors:  Alessandro Inno; Giuseppe Bogina; Monica Turazza; Laura Bortesi; Simona Duranti; Alberto Massocco; Giuseppe Zamboni; Giovanni Carbognin; Filippo Alongi; Matteo Salgarello; Stefania Gori
Journal:  Oncologist       Date:  2015-12-09

Review 4.  Neuroendocrine breast carcinoma: a rare but challenging entity.

Authors:  Elena Trevisi; Anna La Salvia; Lorenzo Daniele; Maria Pia Brizzi; Giovanni De Rosa; Giorgio V Scagliotti; Massimo Di Maio
Journal:  Med Oncol       Date:  2020-07-25       Impact factor: 3.064

5.  Neuroendocrine Differentiated Breast Cancer Cases: A Retrospective Analysis and Literature Review.

Authors:  Ozlem Ozdemir; Baha Zengel; Yasar Yildiz; Seray Saray; Ahmet Alacacioglu; Funda Tasli; Zuleyha Can Erdi; Utku Oflazoglu; Halil Taskaynatan; Tarik Salman; Umut Varol; Zehra Hilal Adibelli; Raika Durusoy; Yuksel Kucukzeybek
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2021-12-29

Review 6.  Primary neuroendocrine carcinoma of the breast with leptomeninges metastasis: A case report and literature review.

Authors:  Mengqi Yuan; Dongmei Chen; Hongliang Sun; Xiuhong Wang; Donggui Wan
Journal:  J Int Med Res       Date:  2022-09       Impact factor: 1.573

7.  Case Report: Extensive Tumor Profiling in Primary Neuroendocrine Breast Cancer Cases as a Role Model for Personalized Treatment in Rare and Aggressive Cancer Types.

Authors:  Dörthe Schaffrin-Nabe; Stefan Schuster; Andrea Tannapfel; Rudolf Voigtmann
Journal:  Front Med (Lausanne)       Date:  2022-06-03

Review 8.  Rare epithelial breast cancer: surgery and adjuvant therapy.

Authors:  Aida Abdelwahed; Muneer Ahmed
Journal:  Transl Cancer Res       Date:  2019-10       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.